{"SPADE_UN_17106": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17106", "Peptide Name": "TAT-NBD", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "YGRKKRRQRRRGTALDWSWLQTE", "Sequence Length": 23, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C128H207N47O34", "Mass": 2948.31, "PI": 11.72, "Net Charge": 6, "Hydrophobicity": -1.98, "Half Life": "Mammalian:2.8 hourYeast:10 minE.coli:2 min", "Literature": [{"Title": "Enhanced targeted anticancer effects and inhibition of tumor metastasis by the TMTP1 compound peptide TMTP1-TAT-NBD.", "Pubmed ID": "22580115", "Reference": "J Control Release. 2012 Aug 10;161(3)893-902.", "Author": "Liu R, Xi L, Luo D, Ma X, Yang W, Xi Y, Wang H, Qian M, Fan L, Xia X, Li K, Wang D, Zhou J, Meng L, Wang S, Ma D.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=22580115"}], "Frequent Amino Acids": "RGK", "Absent Amino Acids": "CFHIMNOPUV", "Basic Residues": 8, "Acidic Residues": 2, "Hydrophobic Residues": 6, "Polar Residues": 15, "Positive Residues": 8, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_N_04906", "Similarity": 1.0, "Sequence": "YGRKKRRQRRR"}, {"SPADE_ID": "SPADE_N_07214", "Similarity": 1.0, "Sequence": "GCGGGYGRKKRRQRRR"}, {"SPADE_ID": "SPADE_N_07216", "Similarity": 1.0, "Sequence": "CGGGYGRKKRRQRRR"}]}}}